FDA Accepts Tris Pharma's ANDA with Paragraph IV Certification for a Generic Equivalent to Delsym
SOUTH BRUNSWICK, N.J., July 16 /PRNewswire/ -- Tris Pharma, Inc., a drug delivery and specialty pharmaceutical company, today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 12-hour sust...Victory Pharma, Inc. Announces FDA Accepts MGX006 NDA for Review
SAN DIEGO, July 13 /PRNewswire/ -- Victory Pharma, Inc. ("Victory") announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for Victory's lead investigational rug, MGX006. If approved, MGX006 will provide patients and healt...FDA Accepts Final Section of NDA Filing for LUCASSIN(R)
- Priority Review Granted - LEBANON, N.J., and CLINTON, N.J., June 12 /PRNewswire/ -- Orphan Therapeutics, LLC and Ikaria Holdings, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the final section of the New Drug Application (NDA) filing seeking marketing a...NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing
KUNMING, China, June 8 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic pro...FDA Accepts Arno Therapeutics' IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
PARSIPPANY, N.J., May 11 /PRNewswire-FirstCall/ -- Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced that the U.S. Food and Drug Administration ("FDA") accepted the Company's Investigational New Drug ("IND") application for the us...Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review
EXTON, Pa., May 8 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (NYSE Amex: ILE ) today announced that the United States Food and Drug Administration ("FDA") has completed its initial review of the Company's Biologics License Application ("BLA") related to its Nasolabial Fold/Wrinkles product can...FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
CHADDS FORD, Pa., March 12 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) and its majority-owned subsidiary Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the complete response submission to...Applied Fiberoptics Family of Halogen Light Sources
Description:...reestanding surgicenters. Twin Beam - Delivers one primary lamp and one backup lamp. The port accepts ACMI fiberoptic cables. A durable system, the Twin Beam lightsource is well suited for surgicenters, operating rooms, and surgeons' offices. ...Optronics DVMR - Digital Surgical Recording System
Description:... Introducing Optronics DVMR, the first digital surgical documentation system designed for the microsurgical operating room environment. DVMR accepts images from a variety of high-resolution cameras for simple integration into any microsurgical suite....Researchers first to 'see' reactive oxygen species in vital enzyme
...ate, the researchers kept it at an extremely low temperature about -280 degrees Fahrenheit. When exposed to the x-rays, the cold flavoprotein rapidly accepts electrons liberated in the sample by the x-ray beam. This starts the enzyme reaction, which progresses a bit further and then becomes trapped in its r...New standard for popular stevia-based sweetener to assure product's quality
...dient. The proposed FCC standard for Rebaudioside A is available for review to all interested parties via the FCC Forumthe mechanism through which USP accepts public comment on standards to be included in the FCCbefore the final standard is published in the compendium. "As U.S. manufacturers begin to inc...Female plant 'communicates' rejection or acceptance of male
...new study, University of Missouri researchers have identified pollen proteins that may contribute to the signaling processes that determine if a plant accepts or rejects individual pollen grains for reproduction. Like humans, the mating game isn't always easy for plants. Plants rely on external factors s...Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinson's Disease
...arkinson's disease flowing into the drug development pipeline by allowing researchers to pursue their most exciting ideas in real time. The Foundation accepts Rapid Response proposals on a rolling basis with no deadline, and funding decisions are made within six weeks of application. Awards of up to $75,000 ...Scientists aim to boost world energy supplies -- with microbes!
...methane gas,' he said. 'Even a small fraction could be a very attractive commercial proposition.' Mindful of environmental considerations, Mr Rafter accepts that burning fossil fuels may contribute to climate change but points out that the world will have to rely on fossil fuels for part of its energy need...U.S. FDA Accepts Aridol(TM) New Drug Application for Review
SYDNEY, Australia, May 13 /PRNewswire-Asia/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL ) today announced it had received notification from the United States Food and Drug Administration (FDA) that the New Drug Application (NDA) for its mannitol bronchial challenge test Aridol(TM) has been accepted...FDA Accepts IND for Arno Therapeutics' Pan-DAC / Akt Inhibitor, AR-42
PARSIPPANY, N.J., March 17 /PRNewswire-FirstCall/ -- Arno Therapeutics, Inc. (OTC Bulletin Board: ARNI), a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced that the U.S. Food and Drug Administration ("FDA") accepted the Company's Investigational New Drug (...FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418
BONITA SPRINGS, Fla., March 4 /PRNewswire/ -- Tigris Pharmaceuticals, Inc., a privately held drug development company, today announced that its Investigational New Drug (IND) application for the Company's geranylgeranyltransferase inhibitor (GGTI-2418) has been accepted by the U.S. Food and Drug A...FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab
THOUSAND OAKS, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN ) today announced that the U.S. Food and Drug Administration (FDA) has accepted Amgen's submission and filed a Biologics License Application (BLA) for denosumab, an investigational RANK Ligand inhibitor. Th...FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review
SEATTLE, Dec. 1 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Biologics License Application (sBLA) for ...NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing
KUNMING, China, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN ) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in ...HT96 Isothermal Block from Novagen
Description:... transfer to samples within the 96-well plate. This block has an improved design that provides greater compatibility with robotic platforms. The block accepts up to four Quarters Competent Cell modules for convenient processing of multiple transformation reactions. With more than one HT96 Isothermal Block in...DNA Engine Tetrad 2 Peltier Thermal Cycler, w/4 x 384-well blocks & motorized lid from Bio-Rad
Description:... The Tetrad 2 thermal cycler is a completely redesigned and updated version of the original Tetrad chassis, and it accepts the full line of well-proven Alpha heat-pump assemblies. It delivers the same precision in thermal performance as the DNA Engine Dyad, and original Te...DNA Engine Tetrad 2 Peltier Thermal Cycler from Bio-Rad
Description:... The Tetrad 2 thermal cycler is a completely redesigned and updated version of the original Tetrad chassis, and it accepts the full line of well-proven Alpha heat-pump assemblies. It delivers the same precision in thermal performance as the DNA Engine Dyad, and original Te...PROTEAN II xi Multi-Cell 2-D Conversion Kit from Bio-Rad
Description:... The PROTEAN II xi multi-cell 2-D conversion kit converts the PROTEAN II xi multi-cell to the PROTEAN II XL multi-cell for a wider format cell that accepts 17 to 18 cm IPG strips....ThermoBrite (120 VAC) from StatSpin
Description:...on and hybridization steps in slide-based (F)ISH procedures, and provides walk-away convenience for clinical and research personnel. The low cost unit accepts a wide range of sample types, is easy to use, and reduces hands-on time by more than 50% while ensuring overall precision and accuracy in all (F)ISH a...Pyrex brand baffled trypsinizing flask, with beaded neck from Sigma-Aldrich
Description:...REX trypsinizing flasks are used for converting homogenous tissue samples into cell suspensions by digestion of connective proteins. Heavy beaded neck accepts cotton plugs. Four extra-deep baffles enhance vigorous agitation. • Height of Baffles mm : 125...